Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Tenable Holdings
TENB
$4.01B
| $1.19M | ﹤0.01% |
39,961
+25,386
| +174% | +$690K |
|
2577
PUT
Tencent Music
TME
$15.6B
| $1.19M | ﹤0.01% |
88,500
-7,600
| -8% | -$90K |
|
2578
CALL
Dentsply Sirona
XRAY
$2.43B
| $1.19M | ﹤0.01% |
27,000
| – | – |
|
2579
Silgan Holdings
SLGN
$4.41B
| $1.19M | ﹤0.01% |
36,670
+35,770
| +3,974% | +$1.16M |
|
2580
CALL
IDEX
IEX
$17.3B
| $1.19M | ﹤0.01% |
7,500
-600
| -7% | -$91.7K |
|
2581
CALL
Marathon Petroleum
MPC
$83.7B
| $1.19M | ﹤0.01% |
31,700
-384,900
| -92% | -$12.4M |
|
2582
Camping World
CWH
$653M
| $1.18M | ﹤0.01% |
43,456
+9,604
| +28% | +$155K |
|
2583
Puma Biotechnology
PBYI
$454M
| $1.18M | ﹤0.01% |
113,161
+10,730
| +10% | +$111K |
|
2584
PUT
VeriSign
VRSN
$26.6B
| $1.18M | ﹤0.01% |
5,700
-15,000
| -72% | -$3.11M |
|
2585
PUT
Fastenal
FAST
$59.5B
| $1.18M | ﹤0.01% |
55,000
-174,400
| -76% | -$3.33M |
|
2586
Kodiak Sciences
KOD
$2.84B
| $1.18M | ﹤0.01% |
21,722
+9,249
| +74% | +$522K |
|
2587
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $1.18M | ﹤0.01% |
+30,166
| New | +$1.15M |
|
2588
Trustmark
TRMK
$2.75B
| $1.18M | ﹤0.01% |
47,925
+26,144
| +120% | +$629K |
|
2589
PUT
Ciena
CIEN
$58.4B
| $1.18M | ﹤0.01% |
21,700
-54,600
| -72% | -$2.71M |
|
2590
WSFS Financial
WSFS
$4.15B
| $1.18M | ﹤0.01% |
40,908
+20,407
| +100% | +$540K |
|
2591
Usana Health Sciences
USNA
$286M
| $1.17M | ﹤0.01% |
15,998
+1,751
| +12% | +$137K |
|
2592
First Bancorp
FBP
$4.38B
| $1.17M | ﹤0.01% |
209,889
+34,878
| +20% | +$189K |
|
|
PACW
2593
DELISTED
PacWest Bancorp
PACW
| $1.17M | ﹤0.01% |
59,503
+5,743
| +11% | +$106K |
|
2594
CALL
Cognizant
CTSH
$26B
| $1.17M | ﹤0.01% |
20,600
-15,100
| -42% | -$811K |
|
|
CWEN.A
2595
DELISTED
Clearway Energy Class A
CWEN.A
| $1.17M | ﹤0.01% |
55,673
+7,721
| +16% | +$151K |
|
2596
Gentherm
THRM
$1.27B
| $1.17M | ﹤0.01% |
29,955
+1,976
| +7% | +$74.8K |
|
2597
CALL
Adient
ADNT
$1.5B
| $1.16M | ﹤0.01% |
70,800
-11,600
| -14% | -$176K |
|
2598
Cars.com
CARS
$660M
| $1.16M | ﹤0.01% |
201,857
-38,589
| -16% | -$213K |
|
|
INVX
2599
Innovex International
INVX
$1.97B
| $1.16M | ﹤0.01% |
38,986
+5,596
| +17% | +$172K |
|
2600
Mativ Holdings
MATV
$711M
| $1.16M | ﹤0.01% |
34,715
+5,182
| +18% | +$156K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.